VFC
50
-4
IVZ
45
2
CAT
44
2
HOG
29
2
UNP
36
3
MAS
40
4
DRI
69
5
LYB
34
16
STX
35
7
R
56
2
HRL
42
-2
CNP
49
2
INTC
36
3
MCD
52
2
ADBE
44
-2
RSG
47
2
BRK.B
13
4
RCL
65
12
FOX
75
5
HUM
34
5
VFC
50
-4
IVZ
45
2
CAT
44
2
HOG
29
2
UNP
36
3
MAS
40
4
DRI
69
5
LYB
34
16
STX
35
7
R
56
2
HRL
42
-2
CNP
49
2
INTC
36
3
MCD
52
2
ADBE
44
-2
RSG
47
2
BRK.B
13
4
RCL
65
12
FOX
75
5
HUM
34
5
Financhill
Back

KalVista Pharmaceuticals 10K Form

Sell
34

KALV
KalVista Pharmaceuticals

Last Price:
$8.68
Seasonality Move:
-3.06%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive KALV News And Ratings

See the #1 stock for the next 7 days that we like better than KALV

KALV Financial Statistics

Sales & Book Value

Annual Sales: $12.7M
Cash Flow: $-39.8M
Price / Cash Flow: 0
Annual Sales: $3.10
Price / Book: 3.33

Profitability

EPS (TTM): -3.69000
Net Income (TTM): $-156.4M
Gross Margin: --
Return on Equity: 0%
Return on Assets: 0%

KalVista Pharmaceuticals Earnings Forecast

Key KalVista Pharmaceuticals Financial Ratios

  • The Interest Expense is 0.00% of Operating Income.
  • Per Share Earnings over the last 13 years have been positive in 5 years.

KalVista Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: KALV
CUSIP: 483497
Website: kalvista.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

KALV Technical Analysis vs Fundamental Analysis

Sell
34
KalVista Pharmaceuticals (KALV) is a Sell

Is KalVista Pharmaceuticals a Buy or a Sell?